In a patient with hypothyroidism who is taking levothyroxine 150 µg tablets and is currently vomiting, how should the levothyroxine be managed?

Management of Levothyroxine in a Vomiting Patient with Hypothyroidism

In a hypothyroid patient on levothyroxine 150 µg who is actively vomiting, switch immediately to crushed levothyroxine tablets suspended in water administered via nasogastric tube (if feeding tube is present), or initiate intravenous levothyroxine at 70% of the oral dose (approximately 105 µg IV daily) until vomiting resolves. 1

Immediate Management Algorithm

Step 1: Assess Vomiting Severity and Duration

• If vomiting is acute (<24-48 hours): The patient can temporarily miss doses without significant clinical consequences due to levothyroxine's long half-life of 6-7 days 2
• If vomiting is prolonged or severe: Immediate alternative administration route is required

Step 2: Choose Alternative Administration Route

Option A - Nasogastric/Enteral Tube (Preferred if available)

• Crush levothyroxine tablets and suspend in water 1
• Interrupt enteral feeding
• Administer the suspension as long as possible after feeding
• Resume feeding at least 1 hour after levothyroxine administration 1
• This maintains approximately 70% absorption similar to oral tablets 1

Option B - Intravenous Administration

• Use 70% or less of the usual oral dose intravenously 1
• For this patient: 150 µg × 0.70 = 105 µg IV daily
• This accounts for the fact that only ~70% of oral levothyroxine is absorbed 1
• Continue until oral intake is tolerated

Option C - Temporary Discontinuation (if vomiting expected to resolve within 2-3 days)

• Given levothyroxine's 6-7 day half-life, brief interruptions are tolerable 2
• Resume full dose once vomiting resolves 1
• No dose adjustment needed for interruptions <6 weeks 1

Critical Considerations for This Specific Patient

High-Dose Context

This patient is on 150 µg daily, which is a substantial replacement dose. Consider:

• Body weight: Full replacement typically requires ~1.6 µg/kg daily 1
• Compliance history: Patients on high doses (>200 µg/d) with persistently elevated TSH often have compliance issues 1
• The vomiting itself may indicate a gastrointestinal condition affecting absorption even before the acute episode

Investigate Underlying Cause of Vomiting

While managing the levothyroxine, simultaneously evaluate for:

• Gastrointestinal infections (e.g., Giardia lamblia can cause malabsorption) 3
• Gastroparesis (especially if diabetic) 4
• Celiac disease, inflammatory bowel disease 5
• Drug interactions causing nausea 1

Post-Vomiting Management

When Oral Intake Resumes

1. Resume full 150 µg dose immediately - no titration needed for short interruptions 1
2. Reinforce proper administration:
   • Take with water 30-60 minutes before breakfast on empty stomach 1
   • Alternative: 4 hours after last meal at bedtime 1
   • Avoid concurrent intake with substances that impair absorption 1

If Malabsorption Suspected

If vomiting was part of a broader gastrointestinal syndrome:

• Consider liquid levothyroxine formulation at the same dose 3, 5, 6
• Liquid formulations have superior absorption profiles in malabsorption states 3, 5
• Softgel capsules are another alternative with better bioavailability 4, 5, 6

Follow-Up Testing

• Check TSH in 4-8 weeks after resuming therapy 1
• If TSH remains elevated despite resumed therapy, investigate:
  • Non-compliance (most common) 1
  • Persistent malabsorption 3, 4, 5
  • Drug/food interactions 1

Common Pitfalls to Avoid

1. Do not reduce the dose when restarting after brief interruption - resume full replacement dose 1
2. Do not use 100% of oral dose if switching to IV - use only 70% to avoid overtreatment 1
3. Do not assume compliance - high-dose requirements often reflect non-adherence rather than true increased need 1
4. Do not overlook gastrointestinal pathology - vomiting may indicate underlying malabsorption that will persist 3, 4, 5